Product Recalls in Massachusetts

Product recalls affecting Massachusetts — including food, drugs, consumer products, medical devices, and vehicles distributed to Massachusetts. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,765 recalls have been distributed to Massachusetts in the last 12 months.

52,647 total recalls
2,765 in last 12 months

Showing 421440 of 13,418 recalls

DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: Lysine for Injection Recalled by GenoGenix LLC Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: Methylene Blue for Injection Recalled by GenoGenix LLC Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: NAD+ (Nicotinamide adenine dinucleotide) Recalled by GenoGenix LLC Due to...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: N-Acetyl-L-Cysteine for Injection Recalled by GenoGenix LLC Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: L-Carnitine for Injection Recalled by GenoGenix LLC Due to Lack of Assurance...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: Cerebrolysin for Injection Recalled by GenoGenix LLC Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: Magnesium Chloride for Injection Recalled by GenoGenix LLC Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: GHK-Cu (Copper Peptide) for Injection Recalled by GenoGenix LLC Due to Lack...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 30, 2025· GenoGenix LLC

Recalled Item: Glycine for Injection Recalled by GenoGenix LLC Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 29, 2025· Amerisource Health Services LLC

Recalled Item: Sucralfate Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024....

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 25, 2025· Alembic Pharmaceuticals Limited

Recalled Item: Doxepin Hydrochloride Capsules Recalled by Alembic Pharmaceuticals Limited...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 24, 2025· Cipla USA, Inc.

Recalled Item: Albuterol Sulfate Recalled by Cipla USA, Inc. Due to Failed Stability...

The Issue: Failed Stability Specifications: Out of specification results was observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 22, 2025· Hikma Pharmaceuticals USA Inc.

Recalled Item: Lorazepam Injection Recalled by Hikma Pharmaceuticals USA Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: An out-of-Specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 21, 2025· Ascend Laboratories, LLC

Recalled Item: Amlodipine and Olmesartan Medoxomil Tablets Recalled by Ascend Laboratories,...

The Issue: Failed Dissolution Specifications: low dissolution results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 21, 2025· Merck & Co. Inc

Recalled Item: Belsomra (suvorexant) tablets Recalled by Merck & Co. Inc Due to Failed...

The Issue: Failed Dissolution Specifications: potential for delayed dissolution of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin injection solution Recalled by AEQUITA PHARMACY...

The Issue: Lack of Processing Controls.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol Recalled by...

The Issue: Lack of Processing Controls.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol Recalled by...

The Issue: Lack of Processing Controls.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2025· AEQUITA PHARMACY

Recalled Item: Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol Recalled by AEQUITA...

The Issue: Lack of Processing Controls.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2025· AEQUITA PHARMACY

Recalled Item: Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol Recalled by...

The Issue: Lack of Processing Controls.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund